Gene · 10221
Papers1,541
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,541
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expanding the phenotype of THRB: a range of macular dystrophies as the major clinical manifestations in patients with a dominant splicing variant. | Front Cell Dev Biol | 2023 | 37547476 | PubTator, text mining | PubMed |
| Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis. | Front Pharmacol | 2023 | 37547337 | PubTator, text mining | PubMed |
| A C/ebpα isoform specific differentiation program in immortalized myelocytes. | Leukemia | 2023 | 37532789 | PubTator, text mining | PubMed |
| TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways. | Sci Rep | 2023 | 37528172 | PubTator, text mining | PubMed |
| A spatiotemporal Notch interaction map from plasma membrane to nucleus. | Sci Signal | 2023 | 37527352 | PubTator, text mining | PubMed |
| The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade. | Cell Rep | 2023 | 37527035 | PubTator, text mining | PubMed |
| Recent advances of exosomal circRNAs in cancer and their potential clinical applications. | J Transl Med | 2023 | 37525158 | PubTator, text mining | PubMed |
| Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome. | Diagnostics (Basel) | 2023 | 37510094 | PubTator, text mining | PubMed |
| Pseudokinases, Tribbles Proteins and Cancer. | Cancers (Basel) | 2023 | 37509210 | PubTator, text mining | PubMed |
| JUN-induced super-enhancer RNA forms R-loop to promote nasopharyngeal carcinoma metastasis. | Cell Death Dis | 2023 | 37479693 | PubTator, text mining | PubMed |
| Clinical and Biochemical Characteristics of Untreated Adult Patients With Resistance to Thyroid Hormone Alpha. | J Endocr Soc | 2023 | 37469961 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| Polymorphisms of TRIB1 genes for coronary artery disease and stroke risk: A systematic review and meta-analysis. | Gene | 2023 | 37414350 | PubTator, text mining | PubMed |
| [Functional diversity of disorder-specific macrophage subtype]. | Nihon Yakurigaku Zasshi | 2023 | 37394548 | PubTator, text mining | PubMed |
| Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients. | Front Oncol | 2023 | 37384286 | PubTator, text mining | PubMed |
| Unraveling molecular characteristic of fluoride neurotoxicity on U87 glial-like cells: insights from transcriptomic and proteomic approach. | Front Cell Neurosci | 2023 | 37362003 | PubTator, text mining | PubMed |
| TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response. | Cell Death Dis | 2023 | 37355685 | PubTator, text mining | PubMed |
| Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia. | Clin Transl Med | 2023 | 37345307 | PubTator, text mining | PubMed |
| Identification of AKI signatures and classification patterns in ccRCC based on machine learning. | Front Med (Lausanne) | 2023 | 37293297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10221/papers?page=7